chemie.pr-Presseportal: Branchenansicht - Chemie
Independent Analyses of the SEAS, SHARP and IMPROVE-IT Studies of Ezetimibe.21.07.2008 | 19:21 SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study
Independent Analyses of the SEAS, SHARP and IMPROVE-IT Studies of Ezetimibe
21.07.2008 21:00:10
University of Oxford Clinical Trial Service Unit and Epidemiological Studies Unit: London (ots/PRNewswire) - The University of Oxford Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU) proposed that the hypothesis-generating results of the SEAS trial of ezetimibe should be tested by reviewing the ...
Lesen Sie hier weiter... |
Drucken |
PDF
Ähnliche Artikel
- Results From the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study
- Update on the SEAS Study
- /C O R R E C T I O N -- Prof Terje Pedersen,SEAS Study Principal Investigator& Head of Steering Committee/
- Sanofi Aventis : New Study Results Support the"Basal Plus" Strategy With LANTUS(R) and APIDRA(R) to Improve Blood Sugar Control in Patients With Type 2 Diabetes
- Largest-Ever Studies on Most Common Form of Adult Leukemia, Show Patients Treated With MabThera Live Longer Without Disease Progressing
- Three Studies Presented at 43rd EASL Strongly Indicate Better Efficacy for PEGASYS in Curing Hepatitis C
- Sanofi Aventis: New Real Life Studies Illustrate Greater A1C Lowering and Cost Benefit Observed With LANTUS(R) Over Detemir and NPH Insulin
- World Gastroenterology Organisation and Danone launch Global Campaign to Improve Digestive Health
- MSD Signs Partnership With BMJ Group
- Trillium Strengthens its Board of Directors
Presseportal.de - University of Oxford Clinical Trial Service Unit and ...
of Oxford Clinical Trial Service Unit and Epidemiological Studies Unit.Independent Analyses of the SEAS, SHARP and IMPROVE-IT Studies of Ezetimibe
Independent Analyses of the SEAS, SHARP and IMPROVE-IT Studies of ...
Independent Analyses of the SEAS, SHARP and IMPROVE-IT Studies of Ezetimibe. [21.7.08] Independent Analyses of the SEAS, SHARP and IMPROVE-IT Studies of Ezetimibe
Results From the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study
The analysis of SHARP and IMPROVE-IT does not support the suggestion of an Both the SHARP study and the analyses of cancer data have been conducted by the
Independent Analyses of the SEAS, SHARP and IMPROVE-IT Studies of Ezetimibe
(ots/PRNewswire) - The University of Oxford Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU) proposed on the analyses of SEAS, SHARP and